Previous 10 | Next 10 |
Recent news releases related news releases and press releases from 11/07/23 07:30:36 on US and Canada Markets.
Data generated by Adaptive’s next-generation sequencing-based MRD assay will support the development and commercialization of investigational medicines for hematologic malignancies SEATTLE, Nov. 07, 2023 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a c...
Multiple data presentations upcoming at AASLD – The Liver Meeting®, including preliminary data from Phase 2a clinical trial combining imdusiran, our RNAi therapeutic, with VTP-300, an HBV antigen-specific immunotherapy Dosing continues in two Phase 2a combination clinical tr...
Securitas AB Interim Report Q3 2023 | January-September 2023 PR Newswire STOCKHOLM , Nov. 7, 2023 /PRNewswire/ -- July–September 2023 Total sales MSEK 40 047 (36 013) Organic sales growth 8 percent (7) Operating income before amortiza...
Vancouver, British Columbia--(Newsfile Corp. - November 7, 2023) - Lithium One Metals Inc. (TSXV: LONE) (FSE: H490) (OTCQB: LOMEF) (the " Company " or " Lithium One ") is pleased to announce results from phase one of its exploration campaign in the James Bay lithium district, Quebec. A systematic...
Completed enrollment for pivotal Phase 3 SAPPHIRE trial evaluating apitegromab; topline data expected in 4Q 2024 Expanding into cardiometabolic disorders with SRK-439, a novel investigational myostatin inhibitor Presented new data supporting proof of concept for SRK-181 in heavily...
2023-11-07 07:15:00 ET Despite Microsoft (NASDAQ: MSFT) being a $2.5 trillion company, the growth it is putting up is mind-boggling. One may think that the law of large numbers, which states that it becomes harder to grow the larger you get, would apply, but that's not the case for ...
Michael J. McElhaugh, Arbutus Co-founder and COO, to Serve as Interim CEO WARMINSTER, Pa., Nov. 07, 2023 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS) (“Arbutus” or the “Company”), a clinical-stage biopharmaceutical company leveraging its exten...
VALEO PHARMA ANNOUNCES APPOINTMENT OF MR. RICHARD LAJOIE TO BOARD OF DIRECTORS Canada NewsWire MONTREAL , Nov. 7, 2023 /CNW/ - Valeo Pharma Inc . (TSX: VPH) (OTCQB: VPHIF) (FSE: VP2) (" Valeo " or the " Company "), a Canadian pharmaceutical company, t...
VALEO PHARMA ANNOUNCES APPOINTMENT OF MR. RICHARD LAJOIE TO BOARD OF DIRECTORS Canada NewsWire MONTREAL , Nov. 7, 2023 /CNW/ - Valeo Pharma Inc . (TSX: VPH) (OTCQB: VPHIF) (FSE: VP2) (" Valeo " or the " Company "), a Canadian pharmaceutical company, t...
LAUSANNE, Switzerland, Nov. 07, 2023 (GLOBE NEWSWIRE) -- ADC Therapeutics SA (NYSE: ADCT) today announced that on October 10, 2023, it received a notice from the New York Stock Exchange (NYSE) that the Company is not in compliance with the continued listing minimum price criteria set forth in Sec...
News, Short Squeeze, Breakout and More Instantly...
Trending Stock
20.92%Change Percent:
Snap Inc. Class A Company Name:
SNAP Stock Symbol:
NYSE Market:
snap.com Website: